Procter & Gamble cmp 13605 by Monthly Chart viewProcter & Gamble cmp 13605 by Monthly Chart view
- Support Zone 12000 to 13100 Price Band
- Resistance Zone 14500 to 15375 Price Band
- Support Zone is under testing retesting phase by Weekly Chart view
- Subject to the Resistance Zone Breakout, one my anticipate for ATH 19250 as 1st target and then sky is the limit.
Proctergamble
PROCTER & GAMBLE HEALTH LTD ANALYSISFOR LEARNING PURPOSE
PROCTER & GAMBLE HEALTH LTD - The current price of PGHL is 6217.00 rupees
I am going to buy this stock because of the reasons as follows-
1. Its coming out from a good consolidation base
2. It broke a strong resistance zone and it's making a 4 year high
3. It is showing better relative strength as it stood strong in volatile times including last week.
4. The risk and reward is favourable. The good part- The stock is not extended.
5. The stock belongs to a sector which is quite strong i.e, Pharma and Healthcare. The sector has done great in last few days.
6. The stock has done almost nothing in last 4 years but before that, it gave some insane returns and so a good rest was needed
I am expecting more from this in coming weeks
I will buy it with minimum target of 35-40% and then will trail after that.
My SL is at 5586.10 rupees
I will be managing my risk.
Procter & Gamble Health Ltd.CMP - 5685 - Looks good for long term investment purpose...
Procter & Gamble Health Ltd
About
P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.
Key Points
Strong Brand Portfolio
Company is one the India’s largest VMS companies, manufacturing and marketing vitamins, minerals and supplements. It has a strong portfolio of various pharma brands such as Evion, Neurobion, Seven seas, Nasivion, Polybion, Cosome and Livogen.
Geographical Presence
Company’s products are sold in ~180 countries and territories. Around 90% revenue comes from the India and 10% from outside India markets.
Manufacturing Facility
The company owns and operates 1 manufacturing facility in Goa.
Change in Distribution Model
During FY23, Co. transitioned from its previous go-to-market model, which was serviced via carrying and forward agents, to a new distributor led go-to-market model by appointing distributors. This transition was completed in April 2023. It also strengthened its partnerships across omni channel stores, increasing the availability and access of its brands across online and offline platforms.
Customer Awareness Programs
On World Diabetes Day 2022, the Company launched a large-scale collective awareness effort on Peripheral Neuropathy which was recognized among India’s top diabetes campaigns by Obesity International. On World Iron Deficiency Day, the Company in partnership with FOGSI initiated the 'Na Na Anemia Bus Yatra', a 40-day Bus Yatra across 20 cities and 5 states of India to create awareness on Iron Deficiency.
Discontinuation of Injections Portfolio
Company plans to source the injections portfolio of its products from a contract manufacturer, hence co. decided to discontinue production of injections at its manufacturing plant in Goa effective September 30, 2023. This step will help co. to achieve cost efficiency and supply optimization.
Acquisition By P&G
In 2018, the company (erstwhile Merck Ltd) was acquired by Procter & Gamble Company of USA as a part of a global transaction to acquire Merck KGaA's international consumer healthcare business for a total of 4.2 billion USD. P&G acquired ~51.8% stake of Merck for ~1,300 Crs INR.
Royalty Expenses
The company pays royalty expenses to its parent company The Procter & Gamble Company, USA. It paid 24 Cr in FY23 compared to ~22 Cr in FY22.
Source: Screener.in
This is just to boost my confidence. No Suggestions for buying. I will keep checking and updating my mistake if last post gone wrong...
Disclosure: I am not SEBI registered. The information provided here is for educational purposes only. I will not be responsible for any of your profit/loss with these suggestions. Consult your financial Adviser before making any decisions.
Procter & Gamble Health Limited : A good Stock to hold Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company provides healthcare products. It is involved in manufacturing and marketing over-the-counter vitamins, minerals, and supplements products for a healthy lifestyle. The Company offers brands, including Cosome, Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion.
The Stock was moving in a range Since Mar 2022. It has broken out this range with a Strong Healthy Green Candle and large Volume. Currently the stock is retesting the support @ 4977.30 and may now start the uptrend if the support is not failed.
The technical Indicators are in favor of Uptrend and the movement is supported by a the GOLDEN CROSS OVER
The Targets and Stop Loss Are as mentioned in the chart. We may see the good Movement from Today itself.
Good Luck !!!
Procter & Gamble India ShortThe stock seems to be flashing 3 sell signals:
-> A topping pattern
-> Break below 200 DMA
-> Break of trendline from 2020 lows
Typical target based on this pattern would be around 12350, which also seems to be very close to the important wave 4 price extreme around 12130